Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

R&D Systems™ SGC UBD253
SDP

Catalog No. RD10193528 Shop All Novus Products
Change view
Click to view available options
Quantity:
10 mg
50 mg
2 product options available for selection
Product selection table with 2 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
RD10193528 50 mg
RD10193526 10 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 2 options available.
2 options
Catalog No. RD10193528 Supplier R&D Systems™ Supplier No. 8074/50

Customers require a valid business account associated to their profile to access pricing and ordering options.

missing translation for 'validMainframeMsg'

A Tocris product, part of R&D Systems.

SGC UBD253 is a potent and selective histone deacetylase 6 (HDAC6-UBD) antagonist (KD = 80 nM, 84 nM and 95 nM determined by ITC, SPR and FP, respectively, for the UBD domain; KD = 0.26 μM and 0.44 μM determined by SPR and FP, respectively, for full length HDAC6). Displays 50-fold selectivity for HDAC6 over other UBD proteins, with the exception of USP16 (15-fold). In live cells, it significantly decreases the interaction between HDAC6 and ISG15 (EC50 = 1.9 μM in a NanoBRET assay). Treatment with SGC UBD253 does not inhibit the catalyitic activity of HDAC6.

Specifications

Chemical Name or Material 3-(8-Chloro-3-(2-((2-methoxybenzyl)amino)-2-oxoethyl)-4-oxo-3,4-dihydroquinazolin-2-yl)propanoic acid
CAS 3033200-03-9
Quantity 50 mg
Product Line Tocris
Target Class II Histone Deacetylases Inhibitors
Molecular Formula C21H20ClN3O5
Purity 98%
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.